MoneyWorks4Me

Cipla’s arm’s Goa facility classified as VAI by USFDA

21 Apr 2025 Evaluate

United States Food and Drug Administration (USFDA) has classified inspection conducted at Cipla’s wholly-owned subsidiary -- Medispray Laboratories’ manufacturing facility located in Goa as Voluntary Action Indicated (VAI). USFDA had conducted the inspection at said facility from January 14 to January 20, 2025.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..